TFAP2B and melanoma: For instance, the AP-2B isoform produced by AS of AP-2 lacks a DNA binding domain and shows an inhibitor effect of the transactivation of AP2 and leads to increased tumorigenicity, anchorage-independent growth, invasiveness and angiogenesis in melanoma [66,67].